/Investor DB

Shah Family Office

Family office

Seed–Growth · 8 people tracked

Find your way into Shah Family Office

Sign up to see every warm intro you have to Shah Family Office

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Shah Family Office team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

SCP is a family investment office that pursues early-stage minority investments across a broad range of industries including enterprise software, semiconductors and electronics, consumer, health and life sciences, and fintech. Alongside direct investing, it commits capital to top-tier institutional funds and co-invests with those managers, using these relationships as a channel for sourcing new companies. The firm also allocates to debt, real estate, energy and renewables, and other alternatives, and is exploring opportunities in entertainment and professional sports.

Source: firm website, verified Oct 3, 2026.

Stage
Seed–Growth
Instruments
Equity · Debt
AUM
$1B
Tracked investments
16
Unicorns
1
IPOs
1

Team · 8 people

from the firm's website & public directories

What they invest in

from 5 of 16 portfolio companies

AI & Machine Learning ×4Healthtech ×3Biotech ×2Advanced Manufacturing ×1AgTech ×1Climate Tech ×1Cloud Computing ×1Data & Infrastructure ×1

HQs:United States×6

Investments · 16 tracked

founders shown can be your intro path
SpaceXspacex.comNASDAQ: SPCX

Revolutionizing space technology to make life multi-planetary

Hawthorne, US

Elon Musk(Founder)inBret Johnsen(Executive Officer)inGwynne Shotwell(Executive Officer, Director)Tom Mueller(Founder)

BoardAntonio Gracias(Director)inSteve Jurvetson(Director)in

Co-investors1/1 Capital137 Ventures1802 Ventures2080 Ventures3Spoke Capital4DX Ventures+211 more

Cyteir Therapeuticscyteir.comin𝕏

Cyteir is a clinical-stage oncology company developing CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters.

BiotechHealthtechCambridge, US

Kevin Mills(Executive Officer, Director)inRonald Goldstein(Executive Officer)inDonald Corcoran(Executive Officer, Director)inMarkus Renschler(Director)in

BoardTimothy Romberger(Director)Barry Mills(Director)

Co-investorsDroia VenturesLightstone VenturesOUP (Osage University Partners)Ally Bridge GroupDe Novo VenturesJanus Henderson Investors+3 more

Hedgehoghedgehogfoods.com𝕏Seed · Jun 2024

Hedgehog uses AI and proprietary bioreactors to optimize fungal cultivation for producing food, biochemicals, animal feed, enzymes, and other products from fungi that can recycle waste.

Advanced ManufacturingAgTechAI & Machine LearningClimate TechFoodTechRoboticsSan Francisco, US

Jamie Balsillie(Founder)inWilson Ruotolo(Founder)inJames Laurence Balsillie Jr.(Executive Officer, Director)Laura D'Asaro(Chief Commercial Officer)

BoardTrey Ward(Director)

Co-investorsCollaborative FundConvergeSiddhi CapitalSoma CapitalY CombinatorCavallo Ventures+8 more

Lamar Healthlamarhealth.cominSeed

Lamar Health provides workflow automation software for specialty pharmacies and infusion organizations, enabling teams to manage prior authorization processes and patient access workflows.

AI & Machine LearningHealthtechMedia & EntertainmentSaaSSan Francisco, US

Eesha Sharma(Founder)inAllister Lundberg(CTO)Hayden Krush(Forward Deployed Engineer)

Co-investorsDniproHealthy VenturesPenny Jar Capital VenturePlug and Play VenturesY CombinatorFlex Capital Partners+5 more

Originorigin.bioin𝕏Seed

Origin generates spatial molecular maps from patient tumor samples to enable cancer biology research in native tissue context.

AI & Machine LearningBiotechHealthtechMedical DevicesSan Francisco, US

Yash Rathod(CEO)inMalhar Bhide(CTO)inFounder of Siren Biotechnology(Founder & CEO, Siren Biotechnology · UCSF)Unnamed MIT Professor(Professor of Computer Science, MIT · Broad Institute)Dean at Grainger College of Engineering, UIUC(Dean, Grainger College of Engineering, UIUC)Viraj Doshi(Founding Engineer)

Co-investorsGlasswing VenturesY CombinatorAndreessen HorowitzPhosphor CapitalTopology Ventures

VAST Datavastdata.comin𝕏

VAST Data builds a global data platform designed to enable AI agents to store, process, and execute tasks.

AI & Machine LearningCloud ComputingData & InfrastructureNew York City, US

Jeff Denworth(Founder)inRenen Hallak(Founder)inAlon Horev(Founder)inShachar Fienblit(Founder)

Co-investors83NorthAccess Ventures (New York)Alpha Square GroupAspire11Bond Capital ManagementCats.vc+19 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Epic SciencesExtendGupshupInventiveNetspeedPayclipPenumbraTop GolfTruvianWeave

Exits · 1

1 IPOs

SpaceXNASDAQ: SPCX

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Shah Family Office made?
Shah Family Office has 16 tracked investments, 1 of which have exited.
What stage does Shah Family Office invest at?
Shah Family Office invests at the Seed, Series A, Growth stages.
What sectors does Shah Family Office focus on?
Shah Family Office focuses on Advanced Manufacturing, Biotech, Cleantech, Consumer, Energy, Enterprise Software, Fintech, Healthtech, Semiconductors.
Who does Shah Family Office co-invest with?
Shah Family Office most often shares deals with 83North, Drive Capital, New Enterprise Associates (NEA), among 24 tracked co-investors.

Similar investors

Featured in lists